Brief

2nd Circ. Denies Rehearing In Tylenol Autism Suits

By Rae Ann Varona · October 16, 2026, 11:07 PM EDT

The Second Circuit on Friday denied a bid by Tylenol maker Kenvue and several retailers to reconsider its ruling that a district court improperly excluded expert testimony for plaintiffs who claim...

To view the full article, register now.

Case Information

Case Title

In Re: Acetaminophen - ASD-ADHD Products Liability Litigation

Case Number

1:22-md-03043

Court

New York Southern

Nature of Suit

Personal Injury: Health Care/Pharmaceutical Personal Injury Product Liability

Date Filed

October 05, 2022


Case Title

In Re: Acetaminophen - ASD-ADHD Products Liability Litigation

Case Number

24-916

Court

Appellate - 2nd Circuit

Nature of Suit

Date Filed

April 10, 2024


Case Title

In Re: Acetaminophen - ASD-ADHD Products Liability Litigation

Case Number

24-1121

Court

Appellate - 2nd Circuit

Nature of Suit

Date Filed

April 26, 2024


Case Title

In Re: Acetaminophen-ASD-ADHD Products Liability Litigation

Case Number

24-2360

Court

Appellate - 2nd Circuit

Nature of Suit

Date Filed

September 10, 2024


Case Title

In Re: Acetaminophen ? ASD?ADHD Products Liability

Case Number

24-2594

Court

Appellate - 2nd Circuit

Nature of Suit

Date Filed

September 30, 2024